Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1987-02-10
1989-05-23
Griffin, Roland W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 61, 536 11, 536117, 536124, A61K 906, A61K 31715
Patent
active
048331317
ABSTRACT:
A new class of soluble phosphorylated glucans is described as well as the process for making the same. According to one embodiment, the soluble phosphorylated glucan is derived from the Yeast Saccharomyces cerevisiae. The soluble phosphorylated glucans are useful for promoting the wound healing process. The soluble phosphorylated glucans are also useful for prophylactic and therapeutic applications against neoplastic, bacteria, viral, fungal and parasitic diseases. The soluble phosphorylated glucans are used either alone or in combination with a known antimicrobial agent for prophylactic and therapeutic antimicrobial applications. Additionally, they may be administered either alone or as a non-toxic adjuvant, in combination with chemotherapy. The soluble phosphorylated glucans are also useful for stimulating macrophage cells, either in vivo or in vitro, to produce a cytotoxic/cyctostatic factor effective against cancer cells.
REFERENCES:
patent: 3081226 (1963-03-01), DiLuzio
patent: 3396082 (1968-08-01), Davis et al.
patent: 4138479 (1979-02-01), Truschiet et al.
patent: 4202966 (1980-05-01), Misaki et al.
patent: 4225673 (1980-09-01), Sugiura et al.
patent: 4237266 (1980-12-01), Sugiura et al.
patent: 4340673 (1982-07-01), Stoudt et al.
patent: 4396611 (1983-09-01), Ducan
patent: 4493894 (1985-01-01), Miyashiro et al.
Barlin et al., in Heterogeneity of Mononuclear Phagocytes, Forster & Landy, eds., Academic Press, New York, pp. 243-252 (1981).
Chesterman et al., Toxicol. Lett. 9: 87-90 (1981).
Chirigos et al., Cancer Res. 38: 1085-91 (1978).
Cozens et al., Toxicol. Lett. 9: 55-64 (1981).
Deimann and Fahimi, J. Exper. Med. 149: 883-97 (1979).
DiLuzio and Riggi, J. Reticuloendothel. Soc. 8: 465-73 (1970).
DiLuzio, Trends in Pharmacol. Sci. 4: 344-47 (1983).
DiLuzio et al., Int'l J. Cancer 24: 773-779 (1979).
Ehrke et al., Int'l J. Immunopharm. 5: 34-42 (1983).
Glovsky et al., J. Reticuloendothel, Soc. 33: 401-13 (1983).
Hassid et al., J. Amer. Chem. Soc. 63: 295-98 (1941).
Holbrook et al., Am. J. Trop. Med. Hyg. 30: 762-68 (1981).
Liu et al., Life Sci. 29: 1027-32 (1981).
Mansell and DiLuzio, in the Macrophage in Neoplasia, Fink, ed., Academic Press, New York, pp. 227-243 (1976).
Niskanen et al., Cancer Res. 38: 1406-09 (1978).
Patchen, Surv. Immunol. Res. 2: 237-42 (1983).
Patchen et al., J. Biol. Res. Mod. 3: 627-633 (1984).
Patchen and Lotzova, Exper. Hematol. 8: 409-22 (1980).
Riggi and DiLuzio, Am. J. Physiol. 200: 297-300 (1961).
Saito, Carbohydrate Res. 58: 293.305 (1977).
Seljelid et al., Exper. Cell Res. 131: 121-29 (1981).
Schultz et al., in Immune Modulation and Control of Neoplasia by Adjuvant Therapy, Chirigos, ed., Raven Press, New York, pp. 241-248 (1978).
Suziuki et al., Gann 60: 273-77 (1969).
Williams et al., Hepatol. 5: 198-205 (1985).
Williams et al., Curr. Chemother. and Infectious Disease, Proc. 11th ICC and 19th ICAAC, pp. 1724-1726 (1980).
Wooles and DiLuzio, Proc. Soc. Exper. Biol. Med. 115: 756-59 (1964).
Yamamura and Azuma, Adv. Immunopharm. 2: 501-07 (1982).
Chihara, Rivista di Immunolog. ed Immunofarm. 5(2): 97-85 (1983).
Song and DiLuzio, in Lysosomes in Biology and Pathology, Dingle et al., eds., 6: 533-47 (1979).
Yosida et al., Adv. Pharmacol. Ther. II 6: 101-12 (1982).
DiLuzio and Williams, in Chemical Regulation of Immunology in Veterinary Medicine, Alan R. Liss, Inc., pp. 443-456 (1984), entitled "The Roll of Glucan in the Prevention and Modification of Microparasitic Diseases".
DiLuzio et al., in The Macrophage in Neoplasia; Academic Press, Inc. New York, pp. 181-198 (1976), entitled "The Employment of Glucan and Glucan Activated Macrophages in the Enhancement of Host Resistance to Malignancies in Experimental Animals".
DiLuzio and Chihara, in Advances in Immunopharmacology Hadden et al., eds., Pergamon Press Oxford and New York, pp. 477-484 (1980).
Browder et al., Int. J. Immunopharmac. 6: 19-26 (1984), entitled "Modification of Post-Operative C. Albicas Sepsis by Glucan Immunostimulation".
Jacques, in Current Concepts in Human Immunology and Cancer Immunomodulation, Serron et al., eds., Elsevier Biomedical Press BV, pp. 429-438 (1982), entitled "Immunomodulator Polysaccharides".
Mansell et al., in Immune Modulation and Control of Neoplasia by Adjuvant Chirigos eds., Raven Press, Inc., pp. 255-280 (1978).
Aoki, in Immunomodulating Agents: Properties and Mechanisms, Chirigos, eds., Marcel Dekker, 20: 63-77 (1984).
Hamuro et al., in Immunomodulating Agents: Properties and Mechanisms, Chirigos, ed. Marcel Dekker, Inc., 20: 409-36 (1984).
Ashworth et al., Exper. Molec. Pathol. Supp. 1: 83-103 (1963), entitled "A Morphologic Study of the Effect of Reticuloendothealial Stimulation upon Hepatic Removal of Minute Particles from the Blood of Rats".
Riggi and DiLuzio, Nature 193: 1292-94 (1962), entitled "Hepatic Function During Reticuloendothelial Hyperfunction and Hyperplasia".
Wooles et al., Rad. Res. 16: 546-54 (1962) entitled "Influence of Pre- and Post-X-Irridation Zymosan Administration on Reticuloendothelial Function".
Bomford and Moreno, Br. J. Cancer 36: 41-48 (1977), entitled "Mechanisms of the Anti-Tumor Effect of Glucans and Fructosans: A Comparison with C. Parrvum".
Burgaleta and Golde, Cancer Res. 37: 1739-42 (1977), entitled "Effect of Glucan on Granulopoiesis and Macrophage Genesis in Mice".
DiLuzio, in Kupffer Cells and Other Liver Sinusoidal Cells, Wisse and Knook eds., Elsevier Amsterdam, pp. 397-306 (1977).
DiLuzio et al., in The Macrophage and Cancer, James et al., eds., Edinburgh Univer. Med. Pres., pp. 181-901 (1977).
Schultz et al., Cancer Res. 37: 3338-43 (1977), entitled "Association of Macrophage Activation with Anti-Tumor Activity by Synthetic and Biologic Agents".
DiLuzio and Williams, Infection and Immun. 20: 804-10 (1978), entitled "Protective Effect of Glucan Against Systemic Staphylococcus aureus Septicemia in Normal and Leukemic Mice".
Wooles and DiLuzio, J. Reticuloendothelial. Soc. 1: 160-69 (1964); entitled "The Phagocytic and Proliferative Response of the Reticuloendothelial System Following Glucan Administration".
Browder et al., in Immunomodulation by Microbial Products and Related Synthetic Compounds, Yamamura et al., eds. Excerpta Medica, Amsterdam, pp. 354-357 (1982).
Cook et al., Infect. Immun. 37: 1261-69 (1982) entitled "Protective Effect of Glucan Against Visceral Leishmaniasis in Hamsters".
Song and DiLuzio, in Lysosomes in Biology and Pathology, Dingle et al., eds. North Holland Press Amsterdam 6: 533-47 (1979).
Popisil et al., Experientia 38: 1232-34 (1982) entitled "Glucan Induced Enhancement of Hemopoietic Recovery in Gamma-Irradiated Mice".
Sasaki et al., J. Pharm. Dyn. 5: 1012-16 (1982), entitled "Effect of Serum from Mice Treated with Antitumor Polysaccharide on Expression of Cytotoxicity by Mouse Periotoneal Macrophages".
Satoh et al., J. Pharm. Dyn. 5: 818-28 (1982), entitled "Elevation of Colony Stimulating Factors in Mouse Serum after Injection of PSK, an Antitumor Polysaccharide".
Jacques et al., in Sinusoidal Liver Cells, Knook et al., eds., Elsevier Biomedical Press, pp. 479-481 (1982).
DiLuzio et al., J. Reticuloendothelial Soc. 7: 731-42 (1970); entitled "Evaluation of the Mechanism of Glucan-Induced Stimulation of the Reticuloendothelial System".
Mansell et al., J. Nat'l Cancer Inst. 54: 571-80 (1975) entitled "Macrophage-Mediated Destruction of Human Malignant Cells in vitro".
Inai et al., J. Immunol. 117: 1256-60 (1976), entitled "Activation of the Alternative Complement Pathway by Water-Insoluble Glucans of Streptococcus mutans: the Relation between their Chemical Structures and Activating Potencies".
Proctor et al., J. Immunopharmacol. 3: 385-94 (1981-82) entitled "Development of a Bioassay for Anti-Tumor Activity of Biological Response Modifers of the Reticuloendoethelial Stimulant Class: Reproducibility of the Bioassay".
Bogwald et al., Scand. J. Immuol. 15: 297-04 (1982) entitled "The Cytotoxic Effect of Mouse Macrophages Stimulated in vitro by a Beta-1,3-D-Glucan from Yeast Cell Walls".
Williams et al., J. Reticuloendothel. Soc. 23: 479-90 (1978), entitled "Protective Effect of
Browder I. William
Williams David L.
Bioglucans, L.P.
Griffin Roland W.
LandOfFree
Soluble phosphorylated glucan: methods and compositions for woun does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble phosphorylated glucan: methods and compositions for woun, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble phosphorylated glucan: methods and compositions for woun will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1730917